Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research and development. This was disclosed at a press briefing in Abuja, on ...

The project, aptly named BRILLIANT, an acronym for “Bringing Innovation to Clinical and Laboratory Research to End HIV in ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

One of the most sought-after vaccines in medicine is the HIV vaccine. When HIV was first discovered in 1981, scientists were optimistic that they would be able to develop a vaccine in a few years.

The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...

Key milestone reached within expected initial timelines with successful set up of cell growth and production of HIV-1 vaccine candidate at bench scal ...

Human CMV gene blocks necessary T cell response; HIV vaccines engineered without the gene being tested in clinical trials ...

The study reconfirms longstanding priorities for vaccine research and development, including HIV, malaria and tuberculosis – ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans. The study, ...